ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

ELEV Elevation Oncology Inc

4.00
0.00 (0.00%)
시간외 단일가
최종 업데이트: 17:40:27
15분 지연
기업명 주식 심볼 시장 주식 타입
Elevation Oncology Inc ELEV 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 4.00 17:40:27
개장가 저가 고가 종가 전일 종가
4.00
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
09/04/202405:30PRNUSElevation Oncology Presents Preclinical Proof-of-Concept..
06/03/202422:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/03/202421:45EDGAR2Form 8-K - Current report
06/03/202421:30PRNUSElevation Oncology Reports Fourth Quarter and Full Year 2023..
06/03/202421:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/03/202406:50PRNUSElevation Oncology to Present Preclinical Proof-of-Concept..
05/03/202406:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202406:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/03/202421:30PRNUSElevation Oncology Appoints Experienced Clinical Development..
28/02/202421:30PRNUSElevation Oncology to Participate in Upcoming Investor..
22/02/202421:30PRNUSElevation Oncology Expands Ongoing Phase 1 Clinical Trial of..
21/02/202407:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202406:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/01/202406:15EDGAR2Form 8-K - Current report
23/01/202406:57EDGAR2Form SC 13G - Statement of acquisition of beneficial..
23/01/202406:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/01/202406:24EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/01/202421:45EDGAR2Form 8-K - Current report
22/01/202421:30PRNUSElevation Oncology Announces Appointment of Darcy Mootz,..
10/01/202406:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/01/202421:40EDGAR2Form 8-K - Current report
05/01/202421:30PRNUSElevation Oncology Announces Program Updates and Upcoming..
22/11/202321:30PRNUSElevation Oncology to Present at the Piper Sandler 35th..
02/11/202320:45EDGAR2Form 8-K - Current report
02/11/202320:30PRNUSElevation Oncology Reports Third Quarter 2023 Financial..
02/11/202320:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
23/09/202305:30EDGAR2Form 8-K - Current report
05/09/202320:30PRNUSElevation Oncology to Present at the H.C. Wainwright 25th..
16/08/202320:45EDGAR2Form 8-K - Current report
16/08/202320:30PRNUSElevation Oncology Announces First Patient Dosed in the..
03/08/202320:45EDGAR2Form 8-K - Current report
03/08/202320:30PRNUSElevation Oncology Reports Second Quarter 2023 Financial..
03/08/202320:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/08/202320:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/07/202305:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/07/202305:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/07/202321:15EDGAR2Form 8-K - Current report
13/07/202321:00PRNUSElevation Oncology Appoints Joseph Ferra as Chief Executive..
09/06/202311:41PRNUSElevation Oncology Announces Pricing of $50 Million Public..
09/06/202305:01PRNUSElevation Oncology Announces Launch of Proposed Public..
03/06/202322:00PRNUSElevation Oncology Highlights First-in-Human Phase 1..
15/05/202320:30PRNUSElevation Oncology Reports First Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock